0001143313-22-000035.txt : 20220628
0001143313-22-000035.hdr.sgml : 20220628
20220628140104
ACCESSION NUMBER: 0001143313-22-000035
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
EFFECTIVENESS DATE: 20220628
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BLONDER TONGUE LABORATORIES INC
CENTRAL INDEX KEY: 0001000683
STANDARD INDUSTRIAL CLASSIFICATION: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
IRS NUMBER: 521611421
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14120
FILM NUMBER: 221048950
BUSINESS ADDRESS:
STREET 1: ONE JAKE BROWN RD
STREET 2: PO BOX 1000
CITY: OLD BRIDGE
STATE: NJ
ZIP: 08857
BUSINESS PHONE: 9086794000
MAIL ADDRESS:
STREET 1: ONE JAKE BROWN ROAD
CITY: OLD BRIDGE
STATE: NJ
ZIP: 08857
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE AMERICAN LLC
CENTRAL INDEX KEY: 0001143313
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5414
MAIL ADDRESS:
STREET 1: 11 Wall Street
CITY: New York
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE MKT LLC
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Amex
DATE OF NAME CHANGE: 20090402
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
25-NSE
1
primary_doc.xml
X0203
0001143313
NYSE AMERICAN LLC
0001000683
BLONDER TONGUE LABORATORIES INC
001-14120
One Jake Brown Road
Old Bridge
NJ
NEW JERSEY
08857
(732) 679-4000
Common Stock
17 CFR 240.12d2-2(b)
Victoria Paper
Manager, Market Watch and Proxy Compliance
2022-06-28
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED COMMON STOCK
The NYSE American LLC (the "Exchange") hereby notifies the Securities and Exchange Commission (the "Commission") of its intention to remove the entire class of the common stock ("'Common Stock") of Blonder Tongue Laboratories Inc (the 'Company') from listing and registration on the Exchange at the opening of business on July 11, 2022, pursuant to the provisions of Rule 12d2-2(b) because, in the opinion of the Exchange, the Common Stock is no longer suitable for continued listing and trading on the Exchange.
The Exchange reached its decision pursuant to Section 1009(a) of the American Company Guide (the "Company Guide") as the Company was unable to demonstrate that it had regained compliance with all of Sections 1003(a)(i), (ii) and (iii) of the Company Guide by the end of maximum 18-month compliance plan period, which expired December 10, 2021.
Pursuant to the above authorization, the Company was notified by letter on December 10, 2021, of the Exchange's intention to initiate delisting proceedings and a press release announcing the initiation of delisting proceedings was issued and posted on the Exchange's website.
The Company had a right to appeal the determination to delist the Common Stock by a Committee of the Board of Directors of the Exchange (the "Panel"), provided that it filed a written request for such a review with the Secretary of the Exchange within seven calendar days of receiving notice of the delisting determination. On December 16, 2021, the Company had requested such review. On June 24, 2022, the Company provided formal notification of its intention to withdraw its request. Consequently, all conditions precedent under SEC Rule 12d2-2(b) to the filing of this application have been satisfied.